ARTICLE | Clinical News
Peregrine preclinical data
April 25, 2005 7:00 AM UTC
In a mouse model of metastatic prostate cancer, VEGF121/rGel inhibited tumor growth and enhanced survival by targeting the tumor vasculature as well as normalizing the number of mature osteoclasts fou...